TITLE

Characterization of the Cutaneous Exanthem in Macaques Infected with a Nef Gene Variant of

AUTHOR(S)
Sasseville, Vito G.; Rottman, James B.; Du, Zhenjian; Veazey, Ronald; Knight, Heather L.; Caunt, Diane; Desrosiers, Ronald C.; Lackner, Andrew A.
PUB. DATE
June 1998
SOURCE
Journal of Investigative Dermatology;Jun98, Vol. 110 Issue 6, p894
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The molecularly cloned viruses known as SIVmac239/R17Y and SIVmac239/YEnef cause extensive lymphocyte activation and induce an acute disease syndrome in macaque monkeys. One manifestation of this syndrome is a severe diffuse cutaneous maculopapular exanthem that is similar to the exanthem associated with HIV‐1 infection. To examine the pathogenesis of this exanthem, biopsies obtained throughout the course of clinically evident rash were examined for the presence of virus by in situ hybridization and immunohistochemistry, and the cellular infiltrate was characterized with respect to cellular immunophenotype and chemokine receptor expression. The onset of rash was associated with abundant simian immunodeficiency virus nucleic acid and protein within perivascular dermal infiltrates and occasionally within intraepithelial cells. Analysis of cellular infiltrates showed that biopsies, obtained on the day of rash onset, were composed of equal numbers of CD4+ and CD8+ lymphocytes and abundant αEβ7 positive cells surrounding vessels with upregulated endothelial E‐selectin. Moreover, by examining virus expression in sequential skin biopsies from the same animal, the clearance of virus and the resolution of rash were associated with an increase in the percentage of cells expressing CD8, the chemokine receptor CXCR3, and GMP‐17, a marker of cytotoxic granules. These results suggest that activated cytotoxic T cells are trafficking to sites of inflammation in the skin and directly or indirectly affect levels of viral replication at these sites.
ACCESSION #
5612323

 

Related Articles

  • Novel Simian Foamy Virus infection of wild Indian rhesus macaque (Macaca mulatta). Nandi, Jayashree S.; Chhangani, Anil K.; Mohnot, Surendra M. // Retrovirology;Jan2011 Supplement 1, Vol. 8, pA215 

    An abstract of the research paper titled,"Innate and adaptive anti-viral immune responses in MS patients treated with interferon-beta", is presented.

  • AIDS vaccine models: Challenging challenge viruses. Feinberg, Mark B.; Moore, John P. // Nature Medicine;Mar2002, Vol. 8 Issue 3, p207 

    Discusses AIDS vaccine models particularly rhesus macaque models. Experimental infection of rhesus monkeys with various simian immunodeficiency virus strains of differing virulence; Use of simian/human immunodeficiency viruses (SHIVs) as challenge viruses; Difference between SHIV-89.6P and...

  • The Rhesus Macaque Pediatric SIV Infection Model - A Valuable Tool in Understanding Infant HIV-1 Pathogenesis and for Designing Pediatric HIV-1 Prevention Strategies. Abel, Kristina // Current HIV Research;Jan2009, Vol. 7 Issue 1, p2 

    Worldwide, the AIDS pandemic continues almost relentlessly. Women are now representing the fastest growing group of newly infected HIV-1 infected patients. The risk of mother-to-child-transmission (MTCT) of HIV-1 increases proportionally as many of these women are of childbearing age. The...

  • Differential Tumor Necrosis Factor alpha Productionin Simian Immunodeficiency Virus--Infected... Newman, Gale W.; Adams, Donna L.; Maslow, Joel N.; Murphy-Corb, Michael; Didier, Peter J. // Clinical Infectious Diseases;3/1/1999, Vol. 28 Issue 3, p514 

    Characterizes the function of macrophages (Mphis) in Rhesus macaques infected with simian immunodeficiency virus and Mycobacterium avium to understand HIV and M. avium interactions. Mechanisms in diminishing tumor necrosis factor alpha production by M. avium; Occurrence of M. avium infections...

  • Viral immunity: How CMV bypasses immune memory. Minton, Kirsty // Nature Reviews Immunology;May2010, Vol. 10 Issue 5, p288 

    The article discusses the study on the mechanism behind the ability of secondary cytomegalovirus (CMV) infections to avoid immune memory. The study conducted a subcutaneous inoculation at low concentrations of a recombinant form of rhesus macaque CMV (RhCMV) that expressed simian...

  • A common rhesus macaque MHC class I molecule which binds a cytotoxic T-lymphocyte epitope in Nef of simian immunodeficiency virus. Horton, Helen; Rehrauer, William; Meek, Eliabeth C.; Shultz, Millicent A.; Piekarczyk, Marian S.; Jing, Peicheng; Carter, Donald K.; Steffen, Susan R.; Calore, Briana; Urvater, Julie A.; Vogel, Thorsten U.; Wilson, Nancy A.; Watkins, David I. // Immunogenetics;Jul2001, Vol. 53 Issue 5, p423 

    Focuses on the importance of simian immunodeficiency virus (SIV) infection of rhesus macaques as a model for the study of HIV infection in humans. Importance in controlling viral replication in infected hosts; Expansion on the utility of the rhesus macaque as a model for vaccine and pathogenesis...

  • Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials. Shedlock, Devon J.; Silvestri, Guido; Weiner, David B. // Nature Reviews Immunology;Oct2009, Vol. 9 Issue 10, p717 

    Rhesus macaques are an important animal model for the study of human disease and the development of vaccines against HIV and AIDS. HIV vaccines have been benchmarked in rhesus macaque preclinical challenge studies using chimeric viruses made up of parts of HIV and simian immunodeficency viruses....

  • Effect of therapeutic immunization using Ad5/35 and MVA vectors on SIV infection of rhesus monkeys undergoing antiretroviral therapy. Shimada, M.; Wang, H.-B.; Kondo, A.; Xu, X.-P.; Yoshida, A.; Shinoda, K.; Ura, T.; Mizuguchi, H.; Klinman, D.; Luo, J.-L.; Bai, H.; Okuda, K. // Gene Therapy;Feb2009, Vol. 16 Issue 2, p218 

    Antiretroviral therapy (ART) effectively slows the progression of AIDS. However, drug resistance and/or toxicity can limit the utility of ART in many patients. In this study, we assessed whether a viral vector-based vaccine can be used as a therapeutic vaccine in simian immunodeficiency virus...

  • Blood Picture and Interferon Status of Monkeys Infected by Simian Latent Viruses. Karal-ogly, D.; Ignatova, I.; Gvaramija, I.; Demenkova, N.; Aphanasjev, N.; Agrba, V. // Bulletin of Experimental Biology & Medicine;Jun2010, Vol. 149 Issue 6, p753 

    The blood picture and interferon status of rhesus macaques infected with one or two simian latent viruses do not differ from those of clinically healthy seronegative monkeys.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics